| PERIOD ENDING | 31-Jan-09 | 31-Oct-08 | 31-Jul-08 | 30-Apr-08 | | Total Revenue | 5,881 | 7,404 | 3,731 | 9,666 | | Cost of Revenue | 1,048 | 423 | 654 | 3,871 | | | Gross Profit | 4,833 | 6,982 | 3,077 | 5,794 | | | Operating Expenses | | Research Development | 6,717 | 6,774 | 4,619 | 5,792 | | Selling General and Administrative | 3,870 | 2,452 | 4,247 | 4,215 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 6,191 | 415 | 415 | 419 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,945) | (2,659) | (6,205) | (4,632) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 2,000 | (39,763) | (13) | | Earnings Before Interest And Taxes | (12,738) | (477) | (46,029) | (4,006) | | Interest Expense | 837 | 870 | 1,124 | 679 | | Income Before Tax | (13,575) | (1,347) | (47,153) | (4,685) | | Income Tax Expense | 0 | 0 | 0 | 0 | | Minority Interest |
-
|
-
|
-
| 401 | | | | Net Income From Continuing Ops | (13,575) | (1,347) | (47,154) | (4,685) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,575) | (1,347) | (47,154) | (4,685) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,575) | ($1,347) | ($47,154) | ($4,685) |
|
0.31% Nasdaq 
0.05%
Income Statement
